Skip to content

Medical emergency? What to do

New European guidelines on pulmonary hypertension provide new 6-group clinical definition

3-RXPublished August 31, 20094 min read

Key points

  • New 2009 Guidelines for the diagnosis and treatment of pulmonary hypertension are made public today.
  • Pulmonary hypertension (the increase of blood pressure within the lung circulation) is a condition which may complicate the majority of heart and of lung diseases, or may develop without a clear initiating cause.
  • * Details for all six clinical groups of pulmonary hypertension are described, including treatment strategies.
  • The new 2009 Guidelines provide a new clinical classification of pulmonary hypertension which identifies six different clinical groups.

New 2009 Guidelines for the diagnosis and treatment of pulmonary hypertension are made public today. The Guidelines have been jointly produced by a Task Force of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS); the Task Force also included experts from the International Society of Heart and Lung Transplantation (ISHLT).

The new 2009 Guidelines provide a new clinical classification of pulmonary hypertension which identifies six different clinical groups. However, whatever the underlying causative mechanism, pulmonary hypertension is characterised by a poor prognosis. Indeed, says Professor Nazzareno Galiè, from the Institute of Cardiology at the University of Bologna, Italy, and Chairperson of the Guidelines Task Force: "It is the multidisciplinary nature of pulmonary hypertension and its severity which have made the new guidelines necessary."

Pulmonary hypertension (the increase of blood pressure within the lung circulation) is a condition which may complicate the majority of heart and of lung diseases, or may develop without a clear initiating cause. The new 2009 Guidelines identify six different clinical groups.

The two most common groups are found in patients with pulmonary hypertension resulting from left heart disease (group 2) or lung diseases (group 3). In fact, as many 60% of patients with severe left heart failure and 50% of those with advanced chronic obstructive lung disease will develop pulmonary hypertension. In contrast, clinical group 1 - defined as "pulmonary arterial hypertension" - identifies a group of relatively young patients (average age 50 years) without a clear cause for its development of. However, despite its low prevalence (up to 50 cases per million population), this group has the most severe form of pulmonary hypertension(2.5 years average survival without treatment).

There are several new findings which differentiate the 2009 Guidelines from earlier ones:

* Details for all six clinical groups of pulmonary hypertension are described, including treatment strategies. This is new and should avoid some of the confusion seen in the past over specific drug therapy.
* A unique diagnostic approach is proposed for recognising affected patients as soon as possible and clearly identifying the different clinical groups.
* Emphasis is given to the identification and risk stratification of patients with the more severe form of the disease, ie, those with pulmonary arterial hypertension (group 1).
* Pulmonary arterial hypertension - group 1 - is the only clinical group provided with specific drug therapy and an evidence-based treatment algorithm. The greatest progress in treatment has been made in this group, with eight drugs from three different pharmacological classes approved by regulatory agencies (a table with updated approvals in different countries is provided). A recent meta-analysis of 23 randomised controlled trials with these compounds has shown a 43% reduction in mortality in pulmonary arterial hypertension patients.
* Definitions of patient status and treatment goals are provided, with indications for follow-up strategy. This will help physicians tailor the most appropriate level of medical treatment for each individual patient.
* The indication for interventional procedures - including lung and heart-lung transplantation - are discussed.
* The particular features of the different types of pulmonary arterial hypertension patients, including paediatric patients, are highlighted.
* The minimal requirements of referral/specialised centres for pulmonary hypertension are discussed, underlining a need for professional clinical competence in the management of such demanding patients.
* Overall 127 graded recommendations have been provided

Says Professor Galiè: "It is our belief that the new Guidelines on the diagnosis and treatment of pulmonary hypertension will provide the medical community with updated theoretical and practical information for the management of patients with this severe condition. And because multiple medical disciplines are involved, the joint Task Force of the ESC and ERS (with the collaboration of members of the ISHLT) has developed a multidisciplinary document which can be applied in the heterogeneous medical structures dedicated to the care of patients with pulmonary hypertension."

###

Contact: Jacquelline Partarrieu
jpartarrieu@escardio.org
0034-600-919-617
European Society of Cardiology

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Heart

Comic Gallagher suffers second heart attack

Just days after being released from treatment following a heart attack and a medically induced coma, comedian Gallagher suffered a second heart attack Sunday. His rep confirms to E! News that the 65-year-old funnyman…

1 min read

Heart

Comedian Gallagher still in medically induced coma

Doctors have decided to wait before bringing the comedian Gallagher out of the medically induced coma he was put in after his heart attack last week in Texas. Doctors had planned to wake the 65-year-old comedian on…

1 min read

Heart

10 Risk Factors for Heart Disease

Heart disease is the number one killer in the world. Several factors that increase the risk for heart disease have been identified by the American Heart Association. Scientific studies have shown significant risk…

5 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.